Zacks Investment Research on MSN20h
PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5Insulet Corporation PODD announced favorable RADIANT trial clinical data for its Omnipod 5 at the 18th International Conference on Advanced Technologies and Treatments for Diabetes (“ATTD”). Omnipod 5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback